News-Medical.Net November 2, 2022
In a recent study soon to be presented at the American Heart Association (AHA) Scientific Sessions 2022*, researchers evaluated the usage of WHDs (wearable health devices) by cardiovascular (CVS) disorder patients and those at an increased risk of CVS disorders in the United States (US).
Background
WHDs are automated devices worn on or close to the human body to measure and track physical activity (PA) and health. The devices could improve CVS disease management through enhanced self-monitoring, with in-built features such as HR (heart rate) monitoring, cardiac electrical activity tracking, and PA measurement.
People using WHDs may increase their PA levels, and their health can be objectively tracked and evaluated during doctor consultations to design prescriptions tailored to an individual’s...